vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Natural Grocers by Vitamin Cottage, Inc. (NGVC). Click either name above to swap in a different company.
Natural Grocers by Vitamin Cottage, Inc. is the larger business by last-quarter revenue ($335.6M vs $205.4M, roughly 1.6× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 3.4%, a 4.9% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 1.6%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $11.6M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 4.4%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Natural Grocers by Vitamin Cottage, Inc. is a U.S.-based specialty retail chain that offers certified organic groceries, dietary supplements, natural personal care items, and eco-friendly household products. It serves health-conscious consumers across multiple U.S. states, following strict quality standards that exclude artificial preservatives, colors, flavors and harmful additives.
COLL vs NGVC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $335.6M |
| Net Profit | $17.0M | $11.3M |
| Gross Margin | 62.5% | 29.5% |
| Operating Margin | 29.6% | 4.4% |
| Net Margin | 8.3% | 3.4% |
| Revenue YoY | 12.9% | 1.6% |
| Net Profit YoY | 35.3% | 14.0% |
| EPS (diluted) | $0.48 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $335.6M | ||
| Q3 25 | $209.4M | $336.1M | ||
| Q2 25 | $188.0M | $328.7M | ||
| Q1 25 | $177.8M | $335.8M | ||
| Q4 24 | $181.9M | $330.2M | ||
| Q3 24 | $159.3M | $322.7M | ||
| Q2 24 | $145.3M | $309.1M | ||
| Q1 24 | $144.9M | $308.1M |
| Q4 25 | $17.0M | $11.3M | ||
| Q3 25 | $31.5M | $11.8M | ||
| Q2 25 | $12.0M | $11.6M | ||
| Q1 25 | $2.4M | $13.1M | ||
| Q4 24 | $12.5M | $9.9M | ||
| Q3 24 | $9.3M | $9.0M | ||
| Q2 24 | $19.6M | $9.2M | ||
| Q1 24 | $27.7M | $8.0M |
| Q4 25 | 62.5% | 29.5% | ||
| Q3 25 | 61.7% | 29.5% | ||
| Q2 25 | 57.7% | 29.9% | ||
| Q1 25 | 54.8% | 30.3% | ||
| Q4 24 | 54.0% | 29.9% | ||
| Q3 24 | 60.8% | 29.6% | ||
| Q2 24 | 62.5% | 29.2% | ||
| Q1 24 | 63.1% | 29.3% |
| Q4 25 | 29.6% | 4.4% | ||
| Q3 25 | 29.7% | 4.6% | ||
| Q2 25 | 18.7% | 4.7% | ||
| Q1 25 | 12.2% | 5.2% | ||
| Q4 24 | 20.9% | 4.0% | ||
| Q3 24 | 21.9% | 3.7% | ||
| Q2 24 | 32.7% | 4.2% | ||
| Q1 24 | 34.1% | 3.7% |
| Q4 25 | 8.3% | 3.4% | ||
| Q3 25 | 15.0% | 3.5% | ||
| Q2 25 | 6.4% | 3.5% | ||
| Q1 25 | 1.4% | 3.9% | ||
| Q4 24 | 6.9% | 3.0% | ||
| Q3 24 | 5.9% | 2.8% | ||
| Q2 24 | 13.5% | 3.0% | ||
| Q1 24 | 19.1% | 2.6% |
| Q4 25 | $0.48 | $0.49 | ||
| Q3 25 | $0.84 | $0.51 | ||
| Q2 25 | $0.34 | $0.50 | ||
| Q1 25 | $0.07 | $0.56 | ||
| Q4 24 | $0.36 | $0.43 | ||
| Q3 24 | $0.27 | $0.38 | ||
| Q2 24 | $0.52 | $0.40 | ||
| Q1 24 | $0.71 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $23.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $220.0M |
| Total Assets | $1.7B | $668.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $23.2M | ||
| Q3 25 | $285.9M | $17.1M | ||
| Q2 25 | $222.2M | $13.2M | ||
| Q1 25 | $197.8M | $21.2M | ||
| Q4 24 | $162.8M | $6.3M | ||
| Q3 24 | $120.0M | $8.9M | ||
| Q2 24 | $271.6M | $13.9M | ||
| Q1 24 | $318.0M | $11.0M |
| Q4 25 | $301.7M | $220.0M | ||
| Q3 25 | $274.8M | $212.4M | ||
| Q2 25 | $232.2M | $202.5M | ||
| Q1 25 | $234.4M | $193.0M | ||
| Q4 24 | $228.8M | $181.9M | ||
| Q3 24 | $234.3M | $174.3M | ||
| Q2 24 | $216.6M | $167.8M | ||
| Q1 24 | $222.2M | $160.0M |
| Q4 25 | $1.7B | $668.6M | ||
| Q3 25 | $1.6B | $670.5M | ||
| Q2 25 | $1.6B | $659.0M | ||
| Q1 25 | $1.6B | $664.6M | ||
| Q4 24 | $1.7B | $648.9M | ||
| Q3 24 | $1.6B | $655.5M | ||
| Q2 24 | $1.1B | $654.4M | ||
| Q1 24 | $1.1B | $656.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $21.1M |
| Free Cash FlowOCF − Capex | $122.4M | $11.6M |
| FCF MarginFCF / Revenue | 59.6% | 3.4% |
| Capex IntensityCapex / Revenue | 0.3% | 2.9% |
| Cash ConversionOCF / Net Profit | 7.25× | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $42.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $21.1M | ||
| Q3 25 | $78.4M | $15.6M | ||
| Q2 25 | $72.4M | $2.9M | ||
| Q1 25 | $55.4M | $34.1M | ||
| Q4 24 | $84.6M | $2.7M | ||
| Q3 24 | $-9.0M | $24.5M | ||
| Q2 24 | $67.4M | $12.4M | ||
| Q1 24 | $61.9M | $20.2M |
| Q4 25 | $122.4M | $11.6M | ||
| Q3 25 | $78.3M | $7.5M | ||
| Q2 25 | $72.4M | $-4.2M | ||
| Q1 25 | $54.6M | $27.6M | ||
| Q4 24 | $84.1M | $-6.9M | ||
| Q3 24 | $-9.2M | $18.0M | ||
| Q2 24 | $67.1M | $3.6M | ||
| Q1 24 | $61.4M | $9.8M |
| Q4 25 | 59.6% | 3.4% | ||
| Q3 25 | 37.4% | 2.2% | ||
| Q2 25 | 38.5% | -1.3% | ||
| Q1 25 | 30.7% | 8.2% | ||
| Q4 24 | 46.2% | -2.1% | ||
| Q3 24 | -5.8% | 5.6% | ||
| Q2 24 | 46.2% | 1.2% | ||
| Q1 24 | 42.3% | 3.2% |
| Q4 25 | 0.3% | 2.9% | ||
| Q3 25 | 0.1% | 2.4% | ||
| Q2 25 | 0.0% | 2.2% | ||
| Q1 25 | 0.4% | 1.9% | ||
| Q4 24 | 0.3% | 2.9% | ||
| Q3 24 | 0.2% | 2.0% | ||
| Q2 24 | 0.2% | 2.9% | ||
| Q1 24 | 0.4% | 3.4% |
| Q4 25 | 7.25× | 1.86× | ||
| Q3 25 | 2.49× | 1.32× | ||
| Q2 25 | 6.05× | 0.25× | ||
| Q1 25 | 22.92× | 2.60× | ||
| Q4 24 | 6.75× | 0.27× | ||
| Q3 24 | -0.96× | 2.72× | ||
| Q2 24 | 3.44× | 1.35× | ||
| Q1 24 | 2.23× | 2.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
